These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice. Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946 [TBL] [Abstract][Full Text] [Related]
8. Post treatment surveillance of type II endometrial cancer patients. Zakhour M; Li AJ; Walsh CS; Cass I; Karlan BY; Rimel BJ Gynecol Oncol; 2013 Dec; 131(3):609-12. PubMed ID: 24051222 [TBL] [Abstract][Full Text] [Related]
9. Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma. Steele E; Umar SA; Bomeisl P; Miedler J; Zanotti KM; Wasman JK; Hunt DC; Abdul-Karim FW Diagn Cytopathol; 2012 Feb; 40(2):138-40. PubMed ID: 20891002 [TBL] [Abstract][Full Text] [Related]
10. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Bodurka-Bevers D; Morris M; Eifel PJ; Levenback C; Bevers MW; Lucas KR; Wharton JT Gynecol Oncol; 2000 Aug; 78(2):187-93. PubMed ID: 10926801 [TBL] [Abstract][Full Text] [Related]
11. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Reddoch JM; Burke TW; Morris M; Tornos C; Levenback C; Gershenson DM Gynecol Oncol; 1995 Nov; 59(2):221-5. PubMed ID: 7590477 [TBL] [Abstract][Full Text] [Related]
12. Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125. Lee JY; Kim JH; Seo JW; Kim HS; Kim JW; Park NH; Song YS Int J Gynecol Cancer; 2016 Oct; 26(8):1434-9. PubMed ID: 27465903 [TBL] [Abstract][Full Text] [Related]
13. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824 [TBL] [Abstract][Full Text] [Related]
14. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Kapali M; Agaram NP; Dabbs D; Kanbour A; White S; Austin RM Cancer; 2007 Feb; 111(1):26-33. PubMed ID: 17262796 [TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of a test to detect metastases for endometrial cancer. Havrilesky LJ; Maxwell GL; Chan JK; Myers ER Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation. Fanning J; Hoffman ML; Andrews SJ; Harrah AW; Feldmeier JJ Gynecol Oncol; 2004 Jun; 93(3):632-6. PubMed ID: 15196856 [TBL] [Abstract][Full Text] [Related]
18. Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence. Orr JM; Barnett JC; Leath CA Gynecol Oncol; 2011 Sep; 122(3):501-4. PubMed ID: 21714992 [TBL] [Abstract][Full Text] [Related]
19. Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. Tergas AI; Havrilesky LJ; Fader AN; Guntupalli SR; Huh WK; Massad LS; Rimel BJ Gynecol Oncol; 2013 Sep; 130(3):421-5. PubMed ID: 23747836 [TBL] [Abstract][Full Text] [Related]
20. A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. Soisson AP; Geszler G; Soper JT; Berchuck A; Clarke-Pearson DL Obstet Gynecol; 1990 Jul; 76(1):106-9. PubMed ID: 2359555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]